Abstract
Background
Non-adherence to medical therapy after liver transplantation is confounded by different methods of measurement.
Aims
(1) To compare the performance of three different methods of measuring non-adherence: (a) biochemical (standard deviation [SD] tacrolimus levels), (b) clinician report, (c) self-report. (2) To identify pre-transplant predictors of post-transplant non-adherence. (3) To evaluate whether SD tacrolimus is an accurate predictor of graft outcomes.
Methods
In this retrospective cohort study, charts of adult recipients of a liver transplant 2003–2009 (sample A, n = 444) were reviewed to determine pre-transplant predictors of non-adherence and clinician report of non-adherence. SD tacrolimus levels were measured between 6 and 18 months post-transplant. A subset of sample A (n = 122) completed a survey on non-adherence. The three methods were compared using linear and logistic regression. Multivariable analysis was used to investigate pre-transplant predictors of non-adherence. In sample B (transplant recipients 1995–2003, n = 544) Cox regression was used to determine the relationship between SD immunosuppressant level and graft failure.
Results
Non-adherence was found in 22–62 % of subjects, with the highest rates indicated by self-report. Clinician report of non-adherence was associated with both self-report and SD tacrolimus. On multivariable analysis, unemployment at time of listing and chart evidence of pre-transplant non-adherence were significant predictors of higher SD of tacrolimus. History of substance abuse and pre-transplant chart evidence of non-adherence were also significant independent predictors of post-transplant chart evidence of non-adherence. Drug variability in the immediate post-transplant setting was independently associated with graft failure over time (hazard ratio 1.005 per unit increase in standard deviation, p = 0.04).
Conclusions
Non-adherence among liver transplant recipients is a common problem associated with increased risk of graft failure. SD tacrolimus can be used to measure non-adherent behavior and perhaps target patients for behavioral interventions.
Similar content being viewed by others
References
Martin AP, Bartels M, Hauss J, Fangmann J. Overview of the MELD score and the UNOS adult liver allocation system. Trans Proc. 2007;39:3169–3174.
Volk M. Personal communication. In: Lieber S, ed. City; 2010.
Aranda-Michel J, Dickson RC, Bonatti H, Crossfield JR, Keaveny AP, Vasquez AR. Patient selection for liver transplant: 1-year experience with 555 patients at a single center. Mayo Clinic Proc. 2008;83:165–168.
Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005;59:13–20.
Denhaerynck K, Dobbels F, Cleemput I, et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Trans Int. 2005;18:1121–1133.
Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83:858–873.
Lisson GL, Rodrigue JR, Reed AI, Nelson DR. A brief psychological intervention to improve adherence following transplantation. Ann Trans. 2005;10:52–57.
Falkenstein K, Flynn L, Kirkpatrick B, Casa-Melley A, Dunn S. Non-compliance in children post-liver transplant. Who are the culprits? Pediatr Trans. 2004;8:233–236.
Stuber ML, Shemesh E, Seacord D, Washington J III, Hellemann G, McDiarmid S. Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients. Pediatr Trans. 2008;12:284–288.
Venkat VL, Nick TG, Bucuvalas JC, Wang Y. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence. Pediatr Trans. 2008;12:67–72.
Shemesh E, Shneider BL, Savitzky JK, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics. 2004;113:825–832.
Morales JM, Varo E, Lazaro P. Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain. Clin Transpl. 2012;26:369–376.
Drent G, Haagsma EB, Geest SD, et al. Prevalence of prednisolone (non)compliance in adult liver transplant recipients. Transpl Int. 2005;18:960–966.
Lamba S, Nagurka R, Desai KK, Chun SJ, Holland B, Koneru B. Self-reported non-adherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors. Clin Transpl. 2012;26:328–335.
Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transpl. 2009;9:35–41.
Osterberg L, Blaschke T. Drug therapy—adherence to medication. N Engl J Med. 2005;353:487–497.
Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009;87:1497–1504.
Chisholm MA. Enhancing transplant patients’ adherence to medication therapy. Clin Transpl. 2002;16:30–38.
Drent G, De Geest S, Haagsma EB. Prednisolone noncompliance and outcome in liver transplant recipients. Transpl Int. 2006;19:342–343.
Telles-Correia D, Barbosa A, Mega I, Monteiro E. Psychosocial predictors of adherence after liver transplant in a single transplant center in Portugal. Prog Transpl. 2012;22:91–94.
Kung M, Koschwanez HE, Painter L, Honeyman V, Broadbent E. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions. Transplantation. 2012;93:958–963.
Dew MA, DiMartini AF, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008;14:159–172.
Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417–1426.
O’Carroll RE, McGregor LM, Swanson V, Masterton G, Hayes PC. Adherence to medication after liver transplantation in Scotland: a pilot study. Liver Transpl. 2006;12:1862–1868.
Medical Outcomes Study Social Support Survey (MOSSS). Available at: http://www.rand.org/health/surveys_tools/mos/mos_socialsupport.html. Accessed 7/2010; Sherbourne CD SA. The MOS social support survey. Soc Sci Med. 1991;32:705–714.
Telles-Correia D, Barbosa A, Mega I, Monteiro E. Adherence correlates in liver transplant candidates. Transpl Proc. 2009;41:1731–1734.
Schafer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transpl. 2008;8:616–626.
Beckebaum S, Iacob S, Sweid D, et al. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation. Transpl Int. 2011;24:666–675.
Dharancy S, Giral M, Tetaz R, Fatras M, Dubel L, Pageaux GP. Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT. Clin Transpl. 2012;26:E293–E299.
Merli M, Di Menna S, Giusto M, et al. Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient. Transpl Proc. 2010;42:1322–1324.
Stilley CS, DiMartini AF, de Vera ME, et al. Individual and environmental correlates and predictors of early adherence and outcomes after liver transplantation. Prog Transpl. 2010;20:58–66; quiz 67.
De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S. Interventions to improve medication-adherence after transplantation: a systematic review. Transpl Int. 2009;22:780–797.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Appendix: Survey Materials
Appendix: Survey Materials
Rights and permissions
About this article
Cite this article
Lieber, S.R., Volk, M.L. Non-Adherence and Graft Failure in Adult Liver Transplant Recipients. Dig Dis Sci 58, 824–834 (2013). https://doi.org/10.1007/s10620-012-2412-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-012-2412-0